Clinical Trials Logo

Clinical Trial Summary

A retrospective parallel group comparison study to support expansion of the indication of the company's FDA approved Spinalogicâ„¢ device to include the cervical spine. The SpinalogicTM device was initially approved by FDA as an adjunct to one- or two-level lumbar fusion (P910066/S011). It is a non-invasive bone growth stimulator (BGS) that generates a combined magnetic field (CMF) that has been proven to accelerate bone healing and fusion in the lumbar spine.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05101057
Study type Observational
Source Encore Medical, L.P.
Contact CLAIRE D WILLIAMS, MA
Phone 19789964243
Email Claire.Willams8@djoglobal.com
Status Recruiting
Phase
Start date November 15, 2021
Completion date June 1, 2022